New York City
Hover your mouse on bar for detailed data.
Methodology“HIV-diagnosed”: calculated as PLWHA “retained in care” plus the estimated number of PLWHA who were out of care, based on a statistical weighting method. This estimated number aims to account for out-migration from NYC, and therefore is different from the total number of people diagnosed and reported with HIV/AIDS in NYC. Source: NYC HIV Surveillance Registry. Method: Xia Q, et al. Proportions of Patients with HIV Retained in Care and Virally Suppressed in New York City and the United States. JAIDS 2015;68(3):351-358.
“Retained in care”: PLWHA with ≥1 VL or CD4 count or CD4 percent drawn in 2017, and reported to NYC HIV surveillance. Source: NYC HIV Surveillance Registry.
“Prescribed ART”: calculated as PLWHA “retained in care” multiplied by the estimated proportion of PLWHA prescribed ART in the previous 12 months (93.2%), based on the proportion of NYC Medical Monitoring Project participants whose medical record included documentation of ART prescription. Source: NYC HIV Surveillance Registry and NYC Medical Monitoring Project, 2016.
“Virally suppressed”: calculated as PLWHA in care with a most recent viral load measurement in 2017 of <200 copies/mL, plus the estimated number of out-of-care 2017 PLWHA with a viral load <200 copies/mL, based on a statistical weighting method. Source: NYC HIV Surveillance Registry. Method: Xia Q, et al. Proportions of Patients With HIV Retained in Care and Virally Suppressed in New York City and the United States. JAIDS 2015;68(3):351-358.
As reported to the New York City Department of Health and Mental Hygiene as of March 31, 2018.
Hover your mouse on bar for detailed data.
MethodologyAs of 2017, CDC introduced a new method1 to estimate the number of people living with undiagnosed HIV in the United States using a CD4-depletion model. The local NYC estimate for the proportion of people living with undiagnosed HIV used for the 2017 care continuum and related calculations is higher than the estimate used in the previously published 2016 care continuum. Therefore, the resulting estimated number of people living with HIV (PLHIV) is higher for 2017, and since the estimated number of PLHIV is the denominator for all other indicators (retained in care, virally suppressed, etc.), these proportions have decreased slightly in the 2017 continuum.
1Song R, et al. Using CD4 Data to Estimate HIV Incidence, Prevalence, and Percent of Undiagnosed Infections in the United States. J Acquir Immune Defic Syndr. 2017 Jan 1;74(1):3-9.
“HIV-diagnosed”: calculated as PLWHA “retained in care” plus the estimated number of PLWHA who were out of care, based on a statistical weighting method. This estimated number aims to account for out-migration from NYC, and therefore is different from the total number of people diagnosed and reported with HIV/AIDS in NYC. Source: NYC HIV Surveillance Registry. Method: Xia Q, et al. Proportions of Patients with HIV Retained in Care and Virally Suppressed in New York City and the United States. JAIDS 2015;68(3):351-358.
“Retained in care”: PLWHA with ≥1 VL or CD4 count or CD4 percent drawn in 2017, and reported to NYC HIV surveillance. Source: NYC HIV Surveillance Registry.
“Prescribed ART”: calculated as PLWHA “retained in care” multiplied by the estimated proportion of PLWHA prescribed ART in the previous 12 months (93.2%), based on the proportion of NYC Medical Monitoring Project participants whose medical record included documentation of ART prescription. Source: NYC HIV Surveillance Registry and NYC Medical Monitoring Project, 2016.
“Virally suppressed”: calculated as PLWHA in care with a most recent viral load measurement in 2017 of <200 copies/mL, plus the estimated number of out-of-care 2017 PLWHA with a viral load <200 copies/mL, based on a statistical weighting method. Source: NYC HIV Surveillance Registry. Method: Xia Q, et al. Proportions of Patients With HIV Retained in Care and Virally Suppressed in New York City and the United States. JAIDS 2015;68(3):351-358.
As reported to the New York City Department of Health and Mental Hygiene as of March 31, 2018.
Hover your mouse on bar for detailed data.
MethodologyAs of 2017, CDC introduced a new method1 to estimate the number of people living with undiagnosed HIV in the United States using a CD4-depletion model. The local NYC estimate for the proportion of people living with undiagnosed HIV used for the 2017 care continuum and related calculations is higher than the estimate used in the previously published 2016 care continuum. Therefore, the resulting estimated number of people living with HIV (PLHIV) is higher for 2017, and since the estimated number of PLHIV is the denominator for the first 90, this value has slightly decreased in 2017.
1Song R, et al. Using CD4 Data to Estimate HIV Incidence, Prevalence, and Percent of Undiagnosed Infections in the United States. J Acquir Immune Defic Syndr. 2017 Jan 1;74(1):3-9.
Hover your mouse on bar for detailed data.
Note: 1.Includes data collected at high-volume NYC medical facilities that care for the majority of HIV-exposed and infected children. Children born outside of NYC are not included in this figure.
2. Children born to HIV-infected mothers are followed for 2 years after birth to determine HIV status. HIV status is indeterminate if child is lost to follow-up.
Data as reported to the NYC Department of Health and Mental Hygiene as of March 31, 2019.
Hover your mouse on bar for detailed data.
Note: 1. MSM=Men who have sex with men; IDU=Injection drug use history
2. IDU includes people reporting both MSM and injection drug use history
3. Risk categories based on gender.
Data as reported to the New York City Department of Health and Mental Hygiene as of March 31, 2018.
Hover your mouse on bar for detailed data.
Note: 1. Intercensal 2015 NYC population.
2. Excludes people known to have been diagnosed outside of NYC.
Hover your mouse on bar for detailed data.
Note: 1. HIV viral load (VL) or CD4 test drawn within 3 months (91 days) of HIV diagnosis, following a 7-day lag.
Hover your mouse on bar for detailed data.
Note: 1.Most recent HIV VL value in year of interest was ≤200 copies/mL.
2. At least one HIV VL/CD4 in the year of interest.
